Background: To compare the patients who underwent open minimally invasive parathyroidectomy (OMIP) and conventional surgical approach for primary hyperparathyroidism.Methods: 50 patients with documented primary hyperparathyroidism who underwent surgery by single surgeon, 25 patients who underwent more conventional neck exploration for parathyroidectomy were chosen to match the OMIP patients. Patient demographics, preoperative calcium and parathyroid hormone levels, operative time, total time in the operating room, time in the recovery room, complications, hospital charges for the operating room, and total hospital charges were analyzed.Results: There was no statistical difference in demographics between the groups. By definition, all patients in the OMIP group and control group are of primary hyperparathyroidism. Mild hypercalcemia in both groups, only 16% of patients in the OMIP group and only 12% in the standard group were considered asymptomatic. The three most common presentations in both groups were fatigue (52% in the OMIP group, 60% in the standard group), renal stones (36% OMIP, 40% standard) and decreased bone density (48% OMIP, 52% standard). Operative time, total time in the operating room, and time in the recovery room were all significantly decreased in the OMIP group. No specific complications observed in both groups. Length of hospital stay and hospital charges are very much significant in both groups. OMIP group has less hospital stay and cost effective.Conclusions: OMIP technique resulted in excellent cure rates for primary hyperparathyroidism while simultaneously decreasing operative time and hospital stays. These resulted in significant cost reductions without compromising patient safety.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.